SCN4A

sodium voltage-gated channel alpha subunit 4
OMIM: 603967, Gene2Phenotype

9 panels

Panel Reviews Mode of inheritance Details
9 panels

Green SCN4A in Mendeliome


Version 1.1891

review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Congenital myopathy 22A, classic, MIM# 620351
  • Congenital myopathy 22B, severe fetal, MIM# 620369
  • Hyperkalemic periodic paralysis, type 2, MIM# 170500
  • Hypokalemic periodic paralysis, type 2, MIM# 613345
  • Myasthenic syndrome, congenital, 16, MIM# 614198
  • Myotonia congenita, atypical, acetazolamide-responsive , MIM#608390
  • Paramyotonia congenita , MIM#168300

Green SCN4A in Paroxysmal Dyskinesia


Level 2: Neurology and neurodevelopmental disorders
Version 0.131

Component of the following Super Panels:

  • Dystonia_Superpanel
  • Neuromuscular Superpanel
  • Tremors_Superpanel
  • review Unknown
    Sources
    • Royal Children's Hospital Neurology Department
    • Expert Review Green
    • Victorian Clinical Genetics Services

    Green SCN4A in Skeletal Muscle Channelopathies


    Level 2: Neurology and neurodevelopmental disorders
    Version 1.1

    Component of the following Super Panels:

  • Myopathy Superpanel
  • Neuromuscular Superpanel
  • review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • Expert Review Green
    • Royal Melbourne Hospital
    Phenotypes
    • Hyperkalemic Periodic Paralysis
    • Hypokalemic periodic paralysis, type 2, 613
    • Thyrotoxic Periodic Paralysis, Susceptibility To, 2
    • Hypokalemic Periodic Paralysis
    • Episodic weakness
    • Myotonia
    • Potassium-Aggravated Myotonia
    • Hyperkalemic periodic paralysis, type 2, 170500
    • Myasthenic syndrome, acetazolamide-responsive, 614198

    Green SCN4A in Congenital Myasthenia


    Level 2: Neurology and neurodevelopmental disorders
    Version 1.10

    Component of the following Super Panels:

  • Neuromuscular Superpanel
  • review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Expert Review Green
    • Royal Melbourne Hospital
    Phenotypes
    • Myasthenic syndrome, congenital, 16, 614198

    Green SCN4A in Rhabdomyolysis and Metabolic Myopathy


    Level 2: Neurology and neurodevelopmental disorders
    Version 1.6

    Component of the following Super Panels:

  • Myopathy Superpanel
  • Neuromuscular Superpanel
  • Progressive Neurological Conditions
  • review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
    Sources
    • Expert Review Green
    • Royal Melbourne Hospital
    Phenotypes
    • Paramyotonia congenita, 168300
    • Myotonia congenita, atypical, acetazolamide-responsive, 608390
    • Hypokalemic periodic paralysis, type 2, 613345
    • Myasthenic syndrome, congenital, 16, 614198
    • Hyperkalemic periodic paralysis, type 2, 170500

    Red SCN4A in Additional findings_Paediatric


    Level 2: Screening
    Version 0.278

    review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • Expert Review Red
    • BabySeq Category C gene
    • BabySeq Category A gene
    Phenotypes
    • Hyperkalemic periodic paralysis, type 2
    • Hypokalemic periodic paralysis, type 2

    Green SCN4A in Fetal anomalies


    Version 1.255

    review BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
    Sources
    • Expert Review Green
    • Genomics England PanelApp
    Phenotypes
    • Congenital myopathy 22B, severe fetal, MIM# 620369
    • Myasthenic syndrome, congenital, 16 MIM#614198

    Red SCN4A in BabyScreen+ newborn screening


    Level 2: Screening
    Version 1.113

    review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
    Sources
    • BabySeq Category C gene
    • BabySeq Category A gene
    • Expert Review Red
    • BeginNGS
    Phenotypes
    • Hyperkalemic periodic paralysis, type 2, MIM# 170500
    • Hypokalemic periodic paralysis, type 2
    • Paramyotonia congenita , MIM#168300
    • Myotonia congenita, atypical, acetazolamide-responsive , MIM#608390
    • Myasthenic syndrome, congenital, 16, MIM# 614198
    • Hyperkalemic periodic paralysis, type 2
    • Hypokalemic periodic paralysis, type 2, MIM# 613345

    Green SCN4A in Renal Tubulopathies and related disorders


    Level 2: Renal and urinary tract disorders
    Version 1.14

    Component of the following Super Panels:

  • Kidneyome_SuperPanel
  • review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
    Sources
    • Expert Review Green
    • Victorian Clinical Genetics Services
    Phenotypes
    • Myotonia congenita, atypical, acetazolamide-responsive , MIM#608390
    • Myasthenic syndrome, congenital, 16, MIM# 614198
    • Hypokalemic periodic paralysis, type 2, MIM# 613345
    • Paramyotonia congenita , MIM#168300
    • Hyperkalemic periodic paralysis, type 2, MIM# 170500